My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.

    Lotery A, Xu X, Zlatava G, Loftus J.

    Br J Ophthalmol. 2007 Oct;91(10):1303-7. Epub 2007 May 15.PMID: 17504847 [PubMed - indexed for MEDLINE]Related articles

    2.

    Burden of illness of neovascular age-related macular degeneration in Canada.

    Cruess A, Zlateva G, Xu X, Rochon S.

    Can J Ophthalmol. 2007 Dec;42(6):836-43.PMID: 18026200 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications]

    Pauleikhoff D, Scheider A, Wiedmann P, Gelisken F, Scholl HP, Roider I, Mohr A, Zlateva G, Xu X.

    Ophthalmologe. 2009 Mar;106(3):242-51. German. PMID: 18709375 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Humanistic burden and health resource utilization among neovascular age-related macular degeneration patients in France]

    Soubrane G, Zlateva G, Xu X, Buggage R, Kosa M.

    J Fr Ophtalmol. 2008 Feb;31(2):138-45. French. PMID: 18401314 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Burden of illness of bilateral neovascular age-related macular degeneration in Spain.

    Ruiz-Moreno JM, Coco RM, García-Arumí J, Xu X, Zlateva G.

    Curr Med Res Opin. 2008 Jul;24(7):2103-11. Epub 2008 Jun 10.PMID: 18547463 [PubMed - indexed for MEDLINE]Related articles

    6.

    Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.

    Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.

    Pharmacoeconomics. 2008;26(1):57-73.PMID: 18088159 [PubMed - indexed for MEDLINE]Related articles

    7.

    Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

    Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J, Goss TF.

    Arch Ophthalmol. 2007 Sep;125(9):1249-54.PMID: 17846366 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.

    Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA; Submacular Surgery Trials Research Group.

    Am J Ophthalmol. 2004 Jul;138(1):91-108.PMID: 15234287 [PubMed - indexed for MEDLINE]Related articles

    9.

    Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.

    Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D, Rapaport MH, Kaplan RM, Brown SI.

    Ophthalmology. 2001 Oct;108(10):1893-900; discussion 1900-1.PMID: 11581068 [PubMed - indexed for MEDLINE]Related articles

    10.

    Vision-related quality of life in patients with bilateral severe age-related macular degeneration.

    Cahill MT, Banks AD, Stinnett SS, Toth CA.

    Ophthalmology. 2005 Jan;112(1):152-8.PMID: 15629836 [PubMed - indexed for MEDLINE]Related articles

    11.

    Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.

    Hudson HL, Lane SS, Heier JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF; IMT-002 Study Group.

    Ophthalmology. 2006 Nov;113(11):1987-2001. Epub 2006 Sep 20.PMID: 16989902 [PubMed - indexed for MEDLINE]Related articles

    12.

    Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.

    Lindblad AS, Clemons TE.

    Arch Ophthalmol. 2005 Sep;123(9):1207-14.PMID: 16157800 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).

    Maguire M; Complications of Age-Related Macular Degeneration Prevention Trial Research Group.

    Ophthalmology. 2004 Jul;111(7):1307-16.PMID: 15234130 [PubMed - indexed for MEDLINE]Related articles

    14.

    The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.

    Tournier M, Moride Y, Lesk M, Ducruet T, Rochon S.

    Can J Clin Pharmacol. 2008 Winter;15(1):e22-35. Epub 2008 Jan 9.PMID: 18579928 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration.

    Miskala PH, Bressler NM, Meinert CL.

    Arch Ophthalmol. 2004 May;122(5):758-66.PMID: 15136325 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vision-related quality of life in patients suffering from age-related macular degeneration.

    Berdeaux GH, Nordmann JP, Colin E, Arnould B.

    Am J Ophthalmol. 2005 Feb;139(2):271-9.PMID: 15733988 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.

    Wolowacz SE, Roskell N, Kelly S, Maciver FM, Brand CS.

    Pharmacoeconomics. 2007;25(10):863-79.PMID: 17887807 [PubMed - indexed for MEDLINE]Related articles

    18.

    Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.

    Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA.

    Ophthalmology. 2005 Jan;112(1):144-51.PMID: 15629835 [PubMed - indexed for MEDLINE]Related articles

    19.

    Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services.

    Scilley K, DeCarlo DK, Wells J, Owsley C.

    Ophthalmic Epidemiol. 2004 Apr;11(2):131-46.PMID: 15255028 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cost-effectiveness model for neovascular age-related macular degeneration: comparing early and late treatment with pegaptanib sodium based on visual acuity.

    Javitt JC, Zlateva GP, Earnshaw SR, Pleil AM, Graham CN, Brogan AJ, Shah SN, Adamis AP.

    Value Health. 2008 Jul-Aug;11(4):563-74. Epub 2007 Dec 17.PMID: 18179676 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity